Day: June 23, 2021

Toronto, Canada, June 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Bubblr Inc., (OTC PINK: BBLR), (“Bubblr” or the “Company”), an ethical technology company focused on the development and commercialization of mobile-first technologies, today announced that it has received an Impact and Licensing report on the Company’s U.S. issued ‘Utility Patent No. US 10977387, AN INTERNET-BASED SEARCH MECHANISM’. The patent supports an Ad-free Marketplace platform that is designed to connect users and suppliers through precision search criteria. When operational, the Bubblr Ad-free platform will uniquely not require any user registration and will provide small and medium-sized businesses access to online customers at a lower cost. Bubblr commissioned the report from Clarivate™ Plc, a global leader in providing...

VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products today announced that Thomas Finetti, partner at Charney IP Law, has been engaged to oversee ongoing patent activities. Based in New Jersey, Charney IP Law concentrates its practice on intellectual property law. The firm’s primary focus is on identifying, protecting, licensing, and enforcing intellectual property rights. They provide strategic advice and representation throughout the product life cycle, from research and development of products and services to financing, licensing, and, if necessary, regulatory approval and the enforcement of the rights obtained. Thomas Finetti brings over 16 years of experience in patent law, combining...

— Initiation of the ABILITY Study, a first-in-human trial, is expected in the third quarter of 2021 — Trial is designed to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of MDNA11 in patients with advanced solid tumors — Preliminary update on safety, PK/PD, and biomarker data expected by year end TORONTO and HOUSTON, June 23, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced that it has submitted a clinical trial application to a Human Research Ethics Committee (HREC) in Australia to initiate a Phase 1/2 clinical study of MDNA11, the Company’s selective, long-acting and novel IL-2 super-agonist. Subject to approval by the HREC and acceptance of the Clinical...

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that it has recently concluded a Type B meeting with the U.S. Food and Drug Administration (“FDA”) regarding omburtamab for the treatment of pediatric patients with CNS/leptomeningeal metastasis from neuroblastoma. At the Type B meeting with the FDA, available data from external historical control groups and plans for statistical analyses to compare such data with the data from Study 03-133 were discussed. Based on our discussions with the FDA, we believe we now have a clearer path towards the resubmission of the omburtamab BLA to the FDA....

Wellteq (CSE.WTEQ) (OTC.WTEQF) has strengthened its collaboration with Garmin® to offer new enterprise wellness solutions in the Asia Pacific region in response to recent COVID-19 surges.Wellteq’s new digital platform focuses on key health indicators to help improve overall wellbeing and increase resistance to COVID-19 with flat-fee, quick-to-launch solutions that include discounted Garmin wearables.Unique to this collaboration, Wellteq will be extending the solution for free to adult family members of employees as many continue to work from the family home.VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) — Wellteq Digital Health Inc. (CSE:WTEQ) (OTC:WTEQF), (the “Company” or “Wellteq”) is pleased to announce the Company has strengthened its collaboration with Garmin®, a leading global provider of smartwatches,...

CHARLOTTE, N.C., June 23, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq: LPLA) today announced that the firm’s proprietary investment management solution, Firm Sleeve, has surpassed $3.4 billion in assets, demonstrating the value of a personalized investment management solution. Built within LPL’s centrally managed Model Wealth Portfolios (MWP) platform, Firm Sleeve delivers scalable, digital and flexible solutions for large firms, registered investment advisors (RIAs) and institutions. The solution gives them the ability to differentiate their investment management offering to attract advisors and serve clients, while reducing the amount of time spent on investment management. “As LPL’s newest advisory capability, Firm Sleeve is rapidly transforming the way that large firms, RIAs and institutions work,” said Rob Pettman, LPL...

Nasdaq CopenhagenLondon Stock ExchangeOther stakeholders Date        23 June 2021 Correction: Re-release of company announcement – now under the category Inside Information Takeover of client portfolio from BIL Danmark (branch of Banque Internationale à Luxembourg S.A., Luxembourg) We are pleased to advise that Ringkjøbing Landbobank has entered into a conditional agreement with Banque Internationale à Luxembourg S.A., of Luxembourg, regarding takeover of all BIL Danmark’s clients. The client portfolio is a good match with Ringkjøbing Landbobank’s Private Banking expertise. At the same time, we can significantly expand the range of products offered to the clients taken over. BIL Danmark has branches in both Copenhagen and Aarhus. The clients taken over will be attached to Ringkjøbing Landbobank’s Private Banking branches in either...

HELENA, Mt., June 23, 2021 (GLOBE NEWSWIRE) — Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), (the “Company” or “Eagle”) announced today the preliminary results of its modified “Dutch auction” tender offer (the “Tender Offer”) to purchase for cash up to $6,000,000 of shares of its common stock (the “Common Stock”) at a price per share not less than $24.00 and not greater than $26.25, which expired at 5:00 p.m., New York City time, on June 22, 2021. Based on the preliminary count by Computershare Trust Company, N.A., the depositary for the tender offer, approximately 847,776 shares of common stock were properly tendered and not withdrawn at a price at or below $26.25 per share, including shares that were tendered through notice of guaranteed delivery. In accordance with the terms and conditions of the Tender Offer, and based on the...

VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC: VSQTF) (FWB:6F6) is pleased to announce that Bill C-218, a bill that legalizes single-game sports wagering has passed the Canadian Senate and now proceeds for Royal Assent to become law in Canada.  Known as The Safe and Regulated Sports Betting Act, Bill C-218 repeals a section of Canada’s criminal code, which makes wagering on a single sporting event outcome illegal in Canada. Victory Square is pleased to have two portfolio companies that will benefit from this announcement: GameOn Entertainment Technologies (CSE:GET) and FansUnite Entertainment (CSE:FANS). Once the Bill C-218 receives Royal Assent, the Company anticipates many opportunities to license and or joint venture across...